Gilead Sciences

Open: 72.28 Close: 72.31 Change: 0.03

Are you looking for information about Gilead Sciences? We programmed an AI to summarize it for you.

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, HIV, GILD, Black, biopharmaceutical, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences has on average historically risen by 22.5% based on the past 32 years of stock performance. CymaBay Therapeutics shares jumped nearly 25% and hit a new record high in early trading. The theme for this years National Black HIV/AIDS Awareness Day is Engage.

Today's News

Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77. FDA Approves Expanded Indication for Gileads Biktarvy® to Treat People with HIV. Gilead Sciences (GILD) closed at $72.31, marking a +0.29% move from the previous day. The theme for this years National Black HIV/AIDS Awareness Day is Engage, Educate, Empower: Uniting to End HIV/ AIDS in Black Communities. Gilead Sciences: National Black HIV/AIDS Awareness Day is Engage, Educate, Empower: Uniting to End HIV/AIDs The biopharmaceutical company said the expans... FDA approved new indication for Biktarvy to treat HIV. Gilead Sciences, Inc. has on average historically risen by 22.5% based on the past 32 years of stock performance. The current share price is $72.29 USD today. CymaBay Therapeutics shares jumped nearly 25% and hit a new record high in early trading after Gilead Sciences agreed to be acquired by the biopharmaceutical company for $4.3 billion. Shares of Kyverna Therapeutic jumped 55.7% in their market debut on Thursday. Gilead Sciences Inc. share was $72.31 on NAS.72, this is a drop of 0.57%. The low in the last 52 weeks was 71.37, the high was 87.86. The current price is 82.11% away from the 52-week high. Chairman and Chief Executive Officer Daniel ODay talks about the companys philanthropic culture and commitment to the Bay Area. Gilead is the second-largest biotech employer in the Bay area. Gilead Sciences (Ticker: GILD) is a resource for investors and traders seeking the latest updates and insights. Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI , detailing the impact and sentiment surrounding the news at the time of release. Gilead Sciences Inc. stock rises friday, still underperforms market - marketwatch.com Analysts Opinions Are Mixed on These Healthcare Stocks: GILD, Travere Therapeutics (TVTX) and 10x Genomics. Gilead Sciences is a research-based biopharmaceutical company. The company announced today that were acquiring CymaBay Therapeutics.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

This document will help you to evaluate Gilead Sciences without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, HIV, GILD, Black, biopharmaceutical, and the most common words in the summary are: gilead, science, stock, inc, job, gild, company, . One of the sentences in the summary was: Gilead Sciences has on average historically risen by 22.5% based on the past 32 years of stock performance. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #stock #inc #job #gild #company.